首页> 外文期刊>FEBS Open Bio >Identification of three predictors of gastric cancer progression and prognosis
【24h】

Identification of three predictors of gastric cancer progression and prognosis

机译:鉴定胃癌进展和预后三种预测因子

获取原文
           

摘要

Abnormal gene expression is an established cause of gastric cancer (GC) initiation and progression. In this study, we aimed to identify several key genes that could be used to effectively predict progression and prognosis in patients with GC. The Cancer Genome Atlas and the Gene Expression Omnibus database were used to identify candidate genes. Fourteen genes were found to associate highly with progress, metastasis, and survival of GC. Five of these genes were overexpressed in tumor tissue compared to adjacent normal tissue. This was confirmed by reverse transcription‐polymerase chain reaction and western blotting for myosin‐Va (MYO5A), phospholipid transfer protein (PLTP), and tripeptidyl peptidase 1 (TPP1), while the CCK8 assay was used to show that these three genes promote GC cell proliferation. In summary, we demonstrate that MYO5A, PLTP, and TPP1 expression may be suitable markers for the progression and prognosis of GC.
机译:异常基因表达是胃癌(GC)引发和进展的既定原因。在这项研究中,我们旨在识别可用于有效预测GC患者的进展和预后的几个关键基因。癌症基因组图集和基因表达综合数据库用于鉴定候选基因。发现十四个基因高度促进GC的进展,转移和存活率。与相邻的正常组织相比,这些基因中的五种在肿瘤组织中过表达。这是通过逆转录 - 聚合酶链反应和霉菌素 - VA(MyO 5a),磷脂转移蛋白(PLTP)和三肽基肽酶1(TPP1)的蛋白质印迹确认,而CCK8测定用于表明这三种基因促进GC细胞增殖。总之,我们证明了MyO5a,PLTP和TPP1表达可能是GC进展和预后的合适标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号